Xtant Medical Holdings Inc XTNT

Morningstar Rating
$0.21 −0.01 (2.82%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

XTNT is trading at a LOCK|Wq<b# premium.
Price
$0.22
Fair Value
LOCK|Lq#lz!%
Uncertainty
LOCK|VY
1-Star Price
LOCK|cn!c<@
5-Star Price
LOCK|CVl%<%
Economic Moat
LOCK|#>!
Capital Allocation
—

News

Trading Information

Previous Close Price
$0.22
Day Range
$0.20–0.25
52-Week Range
$0.17–0.84
Bid/Ask
$0.19 / $0.24
Shares Outstanding
140.45M
Market Cap
$29.49M
Volume/Avg
257,127 / 2M

Key Statistics

Price/Earnings (Normalized)
17.46
Price/Sales
0.31
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
0.21%

Company Profile

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
151

Valuation

Metric
XTNT
Price/Earnings (Normalized)
17.46
Price/Book Value
0.81
Price/Sales
0.31
Price/Cash Flow
—
Price/Earnings
XTNT

Financial Strength

Metric
XTNT
Quick Ratio
0.88
Current Ratio
2.00
Interest Coverage
−4.93
Quick Ratio
XTNT

Profitability

Metric
XTNT
Return on Assets (Normalized)
−13.87%
Return on Equity (Normalized)
−26.45%
Return on Invested Capital (Normalized)
−14.70%
Return on Assets
XTNT

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|rG<g<<%LOCK|lh&Fx$180B
Medtronic PLC
MDT
LOCK|FP&K!F#LOCK|^$>V$$129B
Stryker Corp
SYK
LOCK|#<b<ct@LOCK|<?l$119B
Boston Scientific Corp
BSX
LOCK|>WwbDGbLOCK|rKyW#$62B
Edwards Lifesciences Corp
EW
LOCK|$ztVYchLOCK|BVkJ$60B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|m%?>%!LOCK|yk$37B
DexCom Inc
DXCM
LOCK|?@GT&Q%>LOCK|Fsvl$30B
Koninklijke Philips NV ADR
PHG
LOCK|&X<LOCK|Pf$29B
Steris PLC
STE
LOCK|CxS<>>LOCK|Qcs#@$25B
Zimmer Biomet Holdings Inc
ZBH
LOCK|g&gMs<GlLOCK|jw$19B

Sponsor Center